第 1 到 12 筆結果,共 12 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2020 | The Advantages and Challenges of Using Real-World Data for Patient Care | YUNN-FANG HO ; Hu F.-C.; PING-ING LEE | Clinical and Translational Science | 13 | 11 | |
2 | 2019 | Use of Physiologically Based Pharmacokinetic Modeling to Evaluate the Effect of Chronic Kidney Disease on the Disposition of Hepatic CYP2C8 and OATP1B Drug Substrates | Tan M.-L.; Zhao P.; Zhang L.; YUNN-FANG HO ; Varma M.V.S.; Neuhoff S.; Nolin T.D.; Galetin A.; Huang S.-M. | Clinical Pharmacology and Therapeutics | 55 | 43 | |
3 | 2018 | Trends in reporting drug-associated liver injuries in Taiwan: a focus on amiodarone | Ye, Jun-Hong; YUNN-FANG HO ; On, Angela W-F; Chen, Wen-Wen; YEN-MING HUANG ; Huang, Wei-I; Tang, Yun-Wen | International journal of clinical pharmacy | 8 | 6 | |
4 | 2018 | Comedication with interacting drugs predisposes amiodarone users in cardiac and surgical intensive care units to acute liver injury: A retrospective analysis | YUNN-FANG HO ; Chou H.-Y.; Chu J.-S.; PING-ING LEE | Medicine (United States) | 4 | 3 | |
5 | 2015 | Xanthohumol induces apoptosis and S phase cell cycle arrest in A549 non-small cell lung cancer cells. | YUNN-FANG HO | Pharmacognosy magazine | 0 | 48 | |
6 | 2015 | Nephrotoxic polypharmacy and risk of contrast medium-induced nephropathy in hospitalized patients undergoing contrast-enhanced CT | YUNN-FANG HO ; Hsieh K.-L.; FAN-LU KUNG ; FE-LIN LIN WU ; Hsieh L.-L.; Chou H.; SHYH-JYE CHEN | American Journal of Roentgenology | 12 | 8 | |
7 | 2012 | Does Chinese herb nephropathy account for the high incidence of end-stage renal disease in Taiwan? | FE-LIN LIN WU ; YUNG-MING CHEN ; TAI-SHUAN LAI ; LI-JIUAN SHEN ; YUNN-FANG HO ; Lee, Yi-Ting; Wu, Ming-Show; SHUEI-LIONG LIN ; KWAN-DUN WU | Nephron - Clinical Practice | 12 | ||
8 | 2012 | Oral bisphosphonates and risk of esophageal cancer: A dose-intensity analysis in a nationwide population | Ho, Yunn-Fang ; YUNN-FANG HO ; Lin, Jaw-Town; Wu, Chun-Ying | Cancer Epidemiology Biomarkers and Prevention | 15 | 15 | |
9 | 2012 | Appropriateness of ambulatory prescriptions in Taiwan: Translating claims data into initiatives | LING-LING HSIEH ; FANG-JU LIN ; YUNN-FANG HO | International Journal of Clinical Pharmacy | 4 | 2 | |
10 | 2009 | Effects of St. John's wort extract on indinavir pharmacokinetics in rats: Differentiation of intestinal and hepatic impacts | YUNN-FANG HO | Life Sciences | 16 | 14 | |
11 | 2001 | The COMT L allele modifies the association between MAOB polymorphism and PD in Taiwanese | Kai Hsiang Stanley Chen ; RUEY-MEEI WU ; Cheng C.W; Lu S.L; Shan D.E; YUNN-FANG HO ; Chern H.D. | Neurology | 73 | 61 | |
12 | 2001 | Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions | ANN-LII CHENG ; CHIH-HUNG HSU ; Lin J.-K.; Hsu M.-M.; YUNN-FANG HO ; She T.-S.; JENG-YUH KO ; Lin J.-T.; BOR-RU LIN ; MING-SHIANG WU ; Yu H.-S.; SHIOU-HWA JEE ; Chen G.-S.; Chen T.-M.; CHI-AN CHEN ; Lai M.-K.; YEONG-SHIAU PU ; MIN-HSIUNG PAN ; Wang Y.-J.; Tsai C.-C.; CHANG-YAO HSIEH | Anticancer Research | 1925 | 1695 |